Skip to Content


Active substance(s): MOMETASONE FUROATE

View full screen / Print PDF » Download PDF ⇩


Elocon® Ointment

Read all of this leaflet carefully before you start using this medicine.
– Keep this leaflet. You may need to read it again.
– If you have any further questions, ask your doctor or pharmacist.
– This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same
as yours.
– If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or
In this leaflet:
1. What Elocon is and what it is used for
2. Before you use ELOCON
3. How to use ELOCON
4. Possible side effects
5. How to store ELOCON
6. Further information
ELOCON Ointment is one of a group of medicines called topical corticosteroids. It is classified as a “potent corticosteroid”.
These medicines are put on the surface of the skin to reduce the redness and itchiness caused by certain skin problems.
In adults and children, ELOCON Ointment is used to reduce redness and itchiness caused by certain skin problems called
psoriasis or dermatitis.
Psoriasis is a skin disease in which itchy, scaly, pink patches develop on the elbows, knees, scalp and other parts of the body.
Dermatitis is a condition brought on by the skin reacting to outside agents e.g. detergents, causing the skin to become red and itchy.
Do not use ELOCON
– if you are allergic (hypersensitive) to mometasone furoate, any of the other ingredients of ELOCON or to similar medicines.
– on any other skin problems as it could make them worse especially
– rosacea (a skin condition affecting the face)
– acne
– skin atrophy (thinning of the skin)
– dermatitis around the mouth
– genital itching
– nappy rash
– cold sores
– chickenpox
– shingles
– warts
– ulcerated skin
– wounds
– other skin infections.
Ask your doctor or pharmacist if you are not sure.
Take special care with ELOCON
– if your skin becomes irritated or sensitive after using ELOCON, you should stop using it and tell your doctor
Pregnancy and breast-feeding
You should tell your doctor if you are pregnant or breast-feeding, before you start using ELOCON
Important information about some of the ingredients of Elocon Ointment
Elocon Ointment contains propylene glycolstearate, which can cause skin irritation.
Always use ELOCON exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
ELOCON is not recommended for children under the age of 2.
Usually for adults and children, a thin layer of ELOCON Ointment should be gently rubbed into the affected area of skin once
a day.
You should always follow these instructions when using ELOCON:
– Do not use the ointment on your face for more than 5 days
– Do not apply the ointment to children, on any part of their body, for more than 5 days.
– Do not put the ointment under your child’s nappy, as this makes it easier for the active drug to pass through the skin and
possibly cause some unwanted effects.
– You should check with your doctor before covering the treated areas with a bandage or plaster. Treated areas on the face or
in children should not be covered with a bandage or plaster.

06U014454.indd 1

8/1/11 10:31 AM

– You should not use a large amount of ointment on large areas of the body for a long time (for example every day for many
weeks or months).
– Do not use in or around your eyes, including eye-lids
If you use more ELOCON than you should
If you (or somebody else) accidentally swallows the ointment, it should not produce any problems. However, if you are worried,
you should see your doctor.
If you use the ointment more often than you should, or on large areas of the body, it can affect some of your hormones.
In children, this may affect their growth and development.
If you have not used the cream as you were told to do and have used it too often and/or for a long time, you should tell your
If you forget to use ELOCON
If you forget to use your ointment at the right time, use it as soon as you remember, then carry on as before.
If you stop using ELOCON
If you have been using ELOCON for a long time and your skin problem seems to have got better, you should not suddenly stop
using the ointment. If you do, you may find that your skin becomes red and you may notice stinging or burning. To avoid this,
you should speak to your doctor as he will gradually reduce how often you need to use the ointment until you stop treatment
Like all medicines, ELOCON can cause side effects, although not everybody gets them.
A few people may find that they suffer from some of the following side effects after using ELOCON :
– allergic skin reactions
– bacterial and secondary skin infections
– acne
– inflammation and/ or infection of the hair follicles
– thinning of the skin
– red marks with associated prickly heat
– loss of skin colour
– burning
– stinging
– itching
– tingling
– excessive hair growth
– softening of the skin and stretch marks
Other side effects that may occur with topical corticosteriods are dry skin, skin irritation, dermatitis, dermatitis around the
mouth, and small dilated blood vessels.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
The ointment should be stored between 2 and 30°C.
Keep out of the reach of children.
Do not use ELOCON after the expiry date which is stamped on the pack.
What ELOCON contains
– The active substance is mometasone furoate 0.1 %w/w
– The other ingredients are hexylene glycol; purified water; phosphoric acid; propylene glycol stearate; white bees wax; white
soft paraffin.
What ELOCON looks like and contents of the pack
The ointment is available in a tube containing 5, 15, 30, 45 and 100 g. Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
The holder of the Marketing Authorisation is:
Merck Sharp & Dohme Limited,
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU, UK.
The manufacturer is:
Schering-Plough Labo NV,
Heist-op-den Berg, Belgium.
This leaflet was last approved in
August 2011


06U014454.indd 2

8/1/11 10:31 AM

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.